The necessity of a multidisciplinary approach in the treatment of eating disorders
Abstract
Eating disorders represent complex psychosomatic conditions that require a comprehensive and strictly individualized approach to treatment. The aim of this paper is to present the specific characteristics of the treatment of anorexia nervosa, bulimia nervosa and binge eating disorder, with particular emphasis on nutritional, pharmacological, and psychosocial approaches, focusing on family involvement and social support. The paper examines key principles of treatment, including respect for individual patient characteristics, the influence of family and social environment, and the importance of early intervention. Treatment methods include psychotherapy (individual, behavioral and family therapy), a tailored nutritional plan, monitoring of body weight and overall health status, as well as multidisciplinary coordination among healthcare professionals. The results indicate that a combined approach integrating psychological support and nutritional intervention contributes to gradual weight restoration, reduction of anxiety, and reintegration of patients into everyday life. Special attention is given to stress management, relapse prevention and adaptation to new life routines. It is concluded that a holistic, tactful and humane approach is essential for successful treatment, with continuous support from family and a multidisciplinary team, taking into account both the physical and psychological aspects of the disorder.
References
National Institute for Health and Care Excellence (NICE). Eating disorders: recognition and treatment. London: National Institute for Health and Care Excellence; 2017.
Jurčić Z. Razvojna dimenzija anoreksije i bulimije nervoze. Medix. 2004; 52:40–5.
Royal College of Psychiatrists. Guidelines for the nutritional management of anorexia nervosa. London: Royal College of Psychiatrists; 2005.
Sambol K, Cikač T. Anoreksija i bulimija nervoza – rano otkrivanje i liječenje u obiteljskoj medicini. Medicus. 2015; 24(2):165–9.
Barbarich N. et al. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. Wiley Inter Science 2003;
Rowel D. et al. Eating Disorders:Best Practice Guidelines for Dietitians 2008;Health service executive
Hay P. Current approach to eating disorders: a clinical update. Advances in Psychiatric Treatment. 2020; 26(6):347–55.
Haller E. Eating disorders ‒ A review and update. West J Med 1992;157: 658‒62.
Fairburn CG. Cognitive Behavior Therapy and Eating Disorders. New York (NY): Guilford Press; 2008.
Murphy R, Straebler S, Cooper Z, Fairburn CG. Cognitive behavioral therapy for eating disorders. Psychiatr Clin North Am. 2010; 33(3):611–27.
Agras WS, Walsh BT, Fairburn CG, Wilson GT, Kraemer HC. A multicenter comparison of cognitive‑behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry. 2000; 57(5):459–66.
Dare C, Eisler I, Russell G, Treasure J, Dodge L. Psychological therapies for adults with anorexia nervosa: randomized controlled trial of out‑patient treatments. Br J Psychiatry. 2001; 178(3):216–21.
Loeb KL, Le Grange D, Lock J. Family‑based treatment of eating disorders in adolescents: current insights and evidence. Int J Child Adolesc Health. 2009; 2(2):243–54.
Couturier J, Kimber M, Szatmari P. Efficacy of family‑based treatment for adolescents with eating disorders: a systematic review and meta‑analysis. Int J Eat Disord. 2013; 46(1):3–11.
Safer DL, Robinson AH, Jo B. Outcome from a randomized controlled trial of group therapy for binge eating disorder: comparing dialectical behavior therapy adapted for binge eating to an active comparison group therapy. Behav Ther.2010; 41(1):106–20.
Telch CF, Agras WS, Linehan MM. Dialectical behavior therapy for binge eating disorder: A randomized clinical trial. J Consult Clin Psychol. 2001; 69(6):1061–5.
Fairburn CG, Jones R, Peveler RC, Hope RA, O’Connor M. Psychotherapy and bulimia nervosa: longer‑term effects of interpersonal psychotherapy, behaviour therapy and cognitive behaviour therapy. Arch Gen Psychiatry.1993; 50(6):419–28.
Wilfley DE, Welch RR, Stein RI, Spurrell EB, Cohen LR, Saelens BE, Dounchis JZ, Frank MA, Wiseman CV. A randomized comparison of group cognitive‑behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge‑eating disorder. Arch Gen Psychiatry. 2002; 59(8):713–21.
Yalom ID, Leszcz M. The theory and practice of group psychotherapy. 5th ed. New York (NY): Basic Books; 2005.
Peterson CB, Crosby RD, Wonderlich SA, Mitchell JE, Crow SJ, Engel S. Predicting group cognitive‑behavioral therapy outcome of binge eating disorder using empirical classification. Behaviour Research and Therapy. 2013; 1(9):541–7.
Hay P. A systematic review of evidence for psychological treatments in eating disorders: 2005–2012. Int J Eat Disord. 2013; 46(5):462–9.
Walsh BT, Steinglass JE, et al. Pre‑meal anxiety and food intake in anorexia nervosa. Int J Eat Disord. 2019; 52(3):261–9.
Siopa C, Chaves I, Marques JP, Varino F, Froes P, Pestana PC, Novais F. The Role of New Treatments in Managing Eating Behavior Disorders: A Systematic Review. Curr Treat Options Psychiatry. 2025; 12(1):18.
Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo‑controlled, double‑blind trial. Arch Gen Psychiatry. 1992; 49(2):139–47.
Muratore AF, Attia E. Psychopharmacologic management of eating disorders: a systematic review. Harv Rev Psychiatry. 2022; 30(3):159–73.
Reas DL, Grilo CM, Mitchell JE, et al. Pharmacotherapy of binge‑eating disorder: a review. Psychiatr Clin North Am. 2015; 38(3):519–34.
Rodan SC, Bryant E, Le A, Maloney D, Touyz S, McGregor IS, Maguire S, et al. Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review. J Eat Disord. 2023; 11:112.
Hudson JI, McElroy SL, Ferreira‑Cornwell M, Radewonuk J, Gasior M. Efficacy of lisdexamfetamine in adults with moderate to severe binge‑eating disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(8):841–9.
Crow SJ. Pharmacologic treatment of eating disorders. Curr Psychiatry Rep. 2019;21(10):100.
Sansone RA, Sansone LA. Psychopharmacologic treatment of eating disorders: emerging findings. Innov Clin Neurosci. 2015; 12(5–6):14–9.
Garber AK, Sawyer SM, Golden NH, Guarda AS, Katzman DK, Kohn MR, et al. A prospective examination of weight gain in hospitalized adolescents with anorexia nervosa on a recommended refeeding protocol. J Adolesc Health. 2012; 50(1):24–9.
Dare C, Eisler I, Hodes M, Russell G, Dodge E, Le Grange D. Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions. J Child Psychol Psychiatry. 2001; 42(5):727–36.
Treasure J, Zipfel S, Micali N, et al. Anorexia nervosa. Lancet. 2015; 385(9976):899–911.
Rodgers RF, Paxton SJ, McLean SA. Longitudinal relationships among internalization of the media ideal, peer social comparison, and body dissatisfaction: Implications for the tripartite influence model. Dev Psychol. 2015; 51(5):706–13.
Leonidas C, dos Santos MA. Social support networks and eating disorders: an integrative review of the literature. Neuropsychiatr Dis Treat. 2014; 10:915–27.
Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet. 2010; 375(9714):583–93.
Levine LR. Fluoxetine in the treatment of bulimia nervosa. N Engl J Med. 1992; 327:1835–42.
Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci. 2009; 10:573–84.
Bissada H, Mishra A, Ochner CN, et al. Olanzapine in the treatment of anorexia nervosa: a randomized controlled trial. Am J Psychiatry. 2008; 165(10):1281–8.
Hay P, Bacaltchuk J, Stefano S, Kashyap P. Pharmacotherapy for bulimia nervosa and binge eating disorder: systematic review and meta-analysis. Int J Eat Disord. 2009; 42(2):127–39.
Walsh BT. Pharmacotherapy of eating disorders. Int J Eat Disord. 2011; 44(6):456–62.
